Doe v. Lane Fertility Institute etc. CA1/2

CourtCalifornia Court of Appeal
DecidedJuly 29, 2021
DocketA162094
StatusUnpublished

This text of Doe v. Lane Fertility Institute etc. CA1/2 (Doe v. Lane Fertility Institute etc. CA1/2) is published on Counsel Stack Legal Research, covering California Court of Appeal primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Doe v. Lane Fertility Institute etc. CA1/2, (Cal. Ct. App. 2021).

Opinion

Filed 7/29/21 Doe v. Lane Fertility Institute etc. CA1/2 NOT TO BE PUBLISHED IN OFFICIAL REPORTS California Rules of Court, rule 8.1115(a), prohibits courts and parties from citing or relying on opinions not certified for publication or ordered published, except as specified by rule 8.1115(b). This opinion has not been certified for publication or ordered published for purposes of rule 8.1115.

IN THE COURT OF APPEAL OF THE STATE OF CALIFORNIA

FIRST APPELLATE DISTRICT

DIVISION TWO

JANE DOE, Plaintiff and Respondent, A162094 v. LANE FERTILITY INSTITUTE (Marin County FOR EDUCATION AND Super. Ct. No. CIV 2002299) RESEARCH, INC., et al., Defendants and Appellants.

Defendants Lane Fertility Institute for Education and Research, Inc. and Danielle Lane, M.D., Inc., a Professional Corporation, appeal from the trial court’s order denying their special motion to strike the first amended complaint of plaintiff Jane Doe, pursuant to the provisions of California’s anti-strategic lawsuit against public participation (anti-SLAPP) statute (Code Civ. Proc, § 425.16).1 Defendants contend the court erred in denying their special motion to strike because (1) the entirety of plaintiff’s complaint is based on defendants’ protected activity, and (2) plaintiff did not show a probability of prevailing on the merits. We shall affirm the trial court’s order.

All statutory references are to the Code of Civil Procedure unless 1

otherwise indicated.

1 BACKGROUND Defendants’ business is an alternative reproductive technology (ART) program pursuant to the federal Fertility Clinic Success Rate and Certification Act of 1992 (42 U.S.C. § 263a, et seq.). Defendants are required to submit certain data annually to the Department of Health and Human Services, through the Centers for Disease Control (CDC) in order to keep their certification. (See 42 U.S.C. § 263a, subd. (d)(1)(D).) The data defendants must report includes patient demographics, patient obstetrical and medical history, parental infertility diagnosis, clinical parameters of the ART procedure, and information about resulting pregnancies and births. They report this information to the Society of Assisted Reproductive Technologies (SART), which then transmits the information to the National ART Surveillance System, which ultimately delivers it to the CDC. (See 42 U.S.C. § 263a-1.) The CDC annually publishes the reported pregnancy success rates reported by ART programs. (42 U.S.C. § 263a-5.) In September 2018, plaintiff contacted defendants to engage them in the provision of fertility-related medical services. At that time, defendants provided plaintiff with a written privacy policy, which stated that defendants would contact her only through the means she had specifically designated in writing. Plaintiff designated a private email address as her preferred method of contact, although she also communicated with defendants through a personal work email address. On November 14, 2019, instead of using plaintiff’s designated email address or her personal work email address, defendants sent an email containing personal and sensitive medical information to a general work group email address, g_____@google.com, which goes to plaintiff’s entire work

2 team of nine people at Google and which is monitored by Google’s security, privacy, and practices teams. The email stated: “Hello [plaintiff], “I had emailed you a few weeks ago regarding SART. On behalf of Lane Fertility Institute in regard to your embryo transfer on 12/6/2018 [sic]. I am in the process of reporting data on the success rate of our clinic to the national database, called SART. SART is an organization that reports data regarding IVF and assisted reproductive technology so that it is readily available to patients and clinicians. “Please send me the following information, if you would be so kind: the outcome of the pregnancy (live birth/stillbirth/miscarriage), what method of delivery occurred (vaginal or cesarean), date of birth (or miscarriage), number of fetuses born, gender, and weight.2 “Thanks again for choosing Lane Fertility Institute.” Plaintiff had not informed any of the recipients of the email about the procedures defendants had performed. Since defendants’ disclosure of her personal medical information in the work group email, plaintiff suffered anxiety, mental anguish, and stress about the revelation, and had not returned to her workplace. On July 7, 2020, plaintiff filed her original complaint in this matter, asserting five causes of action, including violation of the Consumer Legal Remedies Act (Civ. Code, § 1750 et seq.); violation of the Confidentiality of

2 Defendants sent this email to the general work group email address at Google after receiving an automated response to a previous similar message they had sent to plaintiff’s personal work email address. The automated response from plaintiff’s personal work email had stated in the subject line: “Out of Office: Maternity Leave.” The body of the email stated: “Thank you for your email! I’m on maternity leave. For immediate assistance, please contact g_____@google.com.”

3 Medical Information Act (Civ. Code, § 56 et seq.); violation of the constitutional right to privacy (Cal. Const., art. I, § 1); violation of the unfair competition law (Bus. & Prof. Code, § 17200 et seq.); and negligence (negligence per se). On October 14, 2020, plaintiff filed the operative first amended complaint, adding a cause of action for public disclosure of private fact. On November 13, 2020, defendants filed a special motion to strike, pursuant to section 425.16. On January 22, 2021, the trial court denied the motion to strike. On February 17, 2021, defendants filed a notice of appeal. DISCUSSION I. Anti-SLAPP Law and Standard of Review Subdivision (b)(1) of section 425.16 provides: “A cause of action against a person arising from any act of that person in furtherance of the person’s right of petition or free speech under the United States Constitution or the California Constitution in connection with a public issue shall be subject to a special motion to strike, unless the court determines that the plaintiff has established that there is a probability that the plaintiff will prevail on the claim.” As relevant here, subdivision (e) of section 425.16 provides: “As used in this section, ‘act in furtherance of a person’s right to petition or free speech under the United States of California Constitution in connection with a public issue’ includes: (1) any written or oral statement or writing made before a legislative, executive, or judicial proceeding, or any other official proceeding authorized by law, (2) any written or oral statement or writing made in connection with an issue under consideration or review by a legislative, executive, or judicial body, or any other official proceeding authorized by law . . . .”

4 “A two-step process is used for determining whether an action is a SLAPP. First, the court decides whether the defendant has made a threshold showing that the challenged cause of action is one arising from protected activity, that is, by demonstrating that the facts underlying the plaintiff’s complaint fits one of the categories spelled out in section 425.16, subdivision (e). If the court finds that such a showing has been made, it must then determine the second step, whether the plaintiff has demonstrated a probability of prevailing on the claim.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Mindys Cosmetics, Inc. v. Dakar
611 F.3d 590 (Ninth Circuit, 2010)
Briggs v. Eden Council for Hope & Opportunity
969 P.2d 564 (California Supreme Court, 1999)
Maranatha Corrections, LLC v. Department of Corrections & Rehabilitation
70 Cal. Rptr. 3d 614 (California Court of Appeal, 2008)
A.F. Brown Electrical Contractor, Inc. v. Rhino Electric Supply, Inc.
41 Cal. Rptr. 3d 1 (California Court of Appeal, 2006)
Olaes v. Nationwide Mutual Insurance
38 Cal. Rptr. 3d 467 (California Court of Appeal, 2006)
Braun v. Chronicle Publishing Co.
52 Cal. App. 4th 1036 (California Court of Appeal, 1997)
Dove Audio, Inc. v. Rosenfeld, Meyer & Susman
47 Cal. App. 4th 777 (California Court of Appeal, 1996)
Blackburn v. Brady
10 Cal. Rptr. 3d 696 (California Court of Appeal, 2004)
Vergos v. McNeal
53 Cal. Rptr. 3d 647 (California Court of Appeal, 2007)
City of Cotati v. Cashman
52 P.3d 695 (California Supreme Court, 2002)
Kibler v. Northern Inyo County Local Hospital District
138 P.3d 193 (California Supreme Court, 2006)
Rand Resources, LLC v. City of Carson
433 P.3d 899 (California Supreme Court, 2019)
Wilson v. Cable News Network, Inc.
444 P.3d 706 (California Supreme Court, 2019)
Hecimovich v. Encinal School Parent Teacher Organization
203 Cal. App. 4th 450 (California Court of Appeal, 2012)
Comstock v. Aber
212 Cal. App. 4th 931 (California Court of Appeal, 2012)
Richmond Compassionate Care Collective v. 7 Stars Holistic Found., Inc.
243 Cal. Rptr. 3d 816 (California Court of Appeals, 5th District, 2019)

Cite This Page — Counsel Stack

Bluebook (online)
Doe v. Lane Fertility Institute etc. CA1/2, Counsel Stack Legal Research, https://law.counselstack.com/opinion/doe-v-lane-fertility-institute-etc-ca12-calctapp-2021.